China Cord Blood (CO) Reports Q2 EPS of RMB0.22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2017
November 17, 2016 4:16 PM ESTHONG KONG, Nov. 17, 2016 /PRNewswire/ --
2Q17 Added 18,037 New Subscribers 2Q17 Revenue Up 7.4% YOY to RMB184.1 Million ($27.6 Million) 2Q17 Operating Income Up 4.3% YOY to RMB54.7 Million ($8.2 Million) Conference Call to be Held on November 18, 2016 at 8:00 a.m. ETChina Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for the second quarter and first half... More
